Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study
- PMID: 29471519
- DOI: 10.1093/cid/ciy146
Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study
Abstract
Background: People living with human immunodeficiency virus (PLWH) are characterized by excess risk of cardiovascular diseases (CVD) and CVD risk factors compared to uninfected individuals. We investigated the association between HIV infection and abdominal obesity, elevated low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and hypertension in a large cohort of predominantly well-treated PLWH and matched controls.
Methods: 1099 PLWH from the Copenhagen Co-morbidity in HIV Infection Study and 12 161 age- and sex-matched uninfected controls from the Copenhagen General Population Study were included and underwent blood pressure, waist, hip, weight, and height measurements and nonfasting blood samples. We assessed whether HIV was independently associated with abdominal obesity, elevated LDL-C, hypertriglyceridemia, and hypertension using logistic regression models adjusted for known risk factors.
Results: HIV infection was associated with higher risk of abdominal obesity (adjusted odds ratio [aOR], 1.92 [1.60-2.30]) for a given body mass index, elevated LDL-C (aOR, 1.32 [1.09-1.59]), hypertriglyceridemia (aOR, 1.76 [1.49-2.08]), and lower risk of hypertension (aOR, 0.63 [0.54-0.74]). The excess odds of abdominal obesity in PLWH was stronger with older age (p interaction, 0.001). Abdominal obesity was associated with elevated LDL-C (aOR, 1.44 [1.23-1.69]), hypertension (aOR, 1.32 [1.16-1.49]), and hypertriglyceridemia (aOR, 2.12 [1.86-2.41]).
Conclusions: Abdominal obesity was associated with proaterogenic metabolic factors including elevated LDL-C, hypertension, and hypertriglyceridemia and remains a distinct HIV-related phenotype, particularly among older PLWH. Effective interventions to reduce the apparent detrimental impact on cardiovascular risk from this phenotype are needed.
Similar articles
-
Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis.J Glob Health. 2024 Apr 26;14:04078. doi: 10.7189/jogh.14.04078. J Glob Health. 2024. PMID: 38666515 Free PMC article.
-
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.BMC Cardiovasc Disord. 2015 Jul 10;15:65. doi: 10.1186/s12872-015-0060-y. BMC Cardiovasc Disord. 2015. PMID: 26160405 Free PMC article.
-
General and abdominal obesity and incident hypertension among people living with HIV on antiretroviral therapy.AIDS Care. 2021 Dec;33(12):1616-1620. doi: 10.1080/09540121.2020.1852158. Epub 2020 Dec 3. AIDS Care. 2021. PMID: 33269606
-
Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors.AIDS. 2019 Mar 15;33(4):675-683. doi: 10.1097/QAD.0000000000002119. AIDS. 2019. PMID: 30585844
-
HIV therapy, metabolic syndrome, and cardiovascular risk.Curr Atheroscler Rep. 2008 Feb;10(1):61-70. doi: 10.1007/s11883-008-0010-6. Curr Atheroscler Rep. 2008. PMID: 18366987 Free PMC article. Review.
Cited by
-
Increased prevalence of hypertension among people living with HIV: where to begin?Rev Soc Bras Med Trop. 2020 Sep 11;53:e20190564. doi: 10.1590/0037-8682-0564-2019. eCollection 2020. Rev Soc Bras Med Trop. 2020. PMID: 32935775 Free PMC article.
-
Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset.Sci Rep. 2019 Dec 6;9(1):18514. doi: 10.1038/s41598-019-54969-3. Sci Rep. 2019. PMID: 31811207 Free PMC article.
-
Metabolic Syndrome in HIV/HCV Co-infected Patients.Curr Treat Options Infect Dis. 2019 Dec;11(4):351-371. doi: 10.1007/s40506-019-00207-3. Epub 2019 Dec 2. Curr Treat Options Infect Dis. 2019. PMID: 32030090 Free PMC article.
-
Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis.J Glob Health. 2024 Apr 26;14:04078. doi: 10.7189/jogh.14.04078. J Glob Health. 2024. PMID: 38666515 Free PMC article.
-
Lysophosphatidylcholines Promote Influenza Virus Reproduction through the MAPK/JNK Pathway in PMA-Differentiated THP-1 Macrophages.Int J Mol Sci. 2024 Jun 13;25(12):6538. doi: 10.3390/ijms25126538. Int J Mol Sci. 2024. PMID: 38928244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical